BioNTech | Results Presentation Deck | 40 slides · page 36 of 40
The slide uses a list-based structure to explain the acquisition of PhagoMed by BioNTech.
Conference presentation · other · illustrate_case · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
image 1/1 list 4/4 subtitle 1/1 title 1/1
Components 7
icon-grid bullet bullet bullet bullet subtitle headline
Tools 2
Audience Definition slide · 70%
Expansion into New Class of Precision Antibacterials with PhagoMed Acquisition
List presentation slide · 80%list/bullet: Total consideration can reach up to ~€150.0 m consisting of upfront consideration of ~€50.0 m (less acquired debt) with the possibility of the selling shareholders earning up to an additional ~€100.0 m; Tran
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.